HopeMed Hopes For First-Line Inroads In Endometriosis-Associated Pain

 
• By Dexter Jie Yan
  
Women's health
Hope Medicine hopes its HMI-115, a prolactin inhibitor, could tackle endometriosis-associated pain in the first-line setting. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from R&D

More from Scrip